According to The Insight Partners market research study on “APAC Multimodal Image Fusion Software Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Type and Application” is expected to reach US$ 125.43 million by 2028 from US$ 63.37 million in 2021. The market is estimated to grow at a CAGR of 8.0% from 2021 to 2028. The report provides trends prevailing in the APAC multimodal image fusion software market along with the drivers and restraints pertaining to the market growth. Rising technological developments in medical imaging is the major factor driving the growth of the APAC multimodal image fusion software market. However, issues associated with the high cost of associated diagnostics equipment hinder the growth of APAC multimodal image fusion software market.
The APAC multimodal image fusion software market is segmented into type, application and country. In terms of type, the multimodal image fusion software market is bifurcated into preclinical multimodal imaging and clinical multimodal imaging. The clinical multimodal imaging segment dominated the market in 2020 and preclinical multimodal imaging segment is expected to be the fastest growing during the forecast period. Based on application, the multimodal image fusion software market is categorized into hospitals, diagnostic centers, and academic and research institutes. The hospitals segment dominated the market in 2020 and diagnostic centers segment is expected to be the fastest growing during the forecast period. Based on country, APAC multimodal image fusion software market is classified into China, Japan, India, Australia, South Korea, and Rest of APAC.
The COVID-19 pandemic has severely impacted APAC due to wide disease spread; countries in this region are among the highly populated countries in the world, which leads to the greater risk infection spread. Many global brands and technological companies are headquartered in the region. According to the Organization for Economic Co-operation and Development (OECD), the pandemic has affected major economies such as China, India, Australia, and Japan, which are experiencing inflation. Governments of APAC countries are taking several possible steps to reduce the effect of pandemic; these efforts include the imposition of lockdown, which has been impacting revenues of various businesses. China and India are among the leading manufacturing sectors in the region, and they are also among highly affected countries in the region. Although the pandemic has negatively impacted several businesses in the region, the healthcare sector has been progressing at an uninterrupted pace (apart from the COVID-19 treatment centers, which experienced a high demand owing to the constantly rising cases). The region homes the two most populated countries of the world, China, and India, which also report rising prevalence of acute diseases such as heart diseases and Alzheimer’s disease, with the growing populations.
Brainlab AG; Bruker Corporation; Carl Zeiss Meditec; FUJIFILM VisualSonics, Inc.; Intrasense SA; Mediso Ltd; MR Solutions Ltd.; and PerkinElmer Inc. are among the leading companies in the APAC multimodal image fusion software market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2018, Bruker Corporation had launched ParaVision 360 preclinical imaging software. It is the most advanced research-grade software for preclinical MRI and had also been extended to nuclear molecular imaging.
Report : Asia Pacific Multimodal Image Fusion Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Preclinical Multimodal Imaging and Clinical Multimodal Imaging), and Application (Hospitals, Diagnostic Centers, and Academic and Research Institutes)
Contact Person: Sameer Joshi
Email Id: firstname.lastname@example.org